hotspot -WSS

hotspot

author：focus 2025-09-27 22:46:06 - browse：8441

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

WSS

For AI in health care standards, federal regulators join with industry group

The untold story of TV’s first prescription drug ad

Microsoft's Peter Lee: Generative AI could help doctors be more human

Alabama frozen embryo ruling has major implications for IVF clinics

Immune cells and nerve overgrowth may explain recurring UTI pain

A new nitrogen execution bill also undermines medical licensing

focus

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medicare drug price negotiation continues, as pharma counteroffers

Affirmative action in medical school literally saved lives

Immune cells and nerve overgrowth may explain recurring UTI pain

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

In Memoriam: Notable people who died in 2023

STAT readers on older presidents, polypills, Medicare, and more

Anesthesiologist group: stop taking Ozempic before surgery

With competition flaring, obesity drug hits goal in liver disease study

focus

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Pregnant women don't need prenatal multivitamins, study concludes

A new approach to psychiatric drug development

IVF doctors demand details after CooperSurgical lawsuit

Streamlined flu vaccines recommended by FDA advisory panel

explore

hotspot

entertainment

explore